MAPT and Cognitive impairment: Overall, longitudinal in vivo tau PET imaging with 18F-THK5351 demonstrated tau-related pathology that was progressive and occurred concomitantly with enhanced histological and biochemical levels of tau, as well as motor and cognitive impairment in P301S mice.